Turcot's syndrome (TS) was originally described as familial predisposition to cancer of the large bowel and brain [1], and is a phenotypic variant of Hereditary Non-Polyposis Colorectal Cancer (HNPCC). HNPCC is caused by germline mutations in one of the DNA mismatch-repair (MMR)-genes MLH1, PMS1, PMS2, MSH2, or MSH6. Identification of HNPCC is based upon clinicopathological features including Background Turcot's syndrome is characterized clinically by the concurrence of a primary brain tumor and multiple colorectal adenomas. We attempted to define the syndrome at the molecular level. OMIM currently includes "Turcot syndrome" under Mismatch repair cancer syndrome. Turcot syndrome is the association between familial polyposis of the colon and brain tumors like medulloblastoma, malignant glioma. It was first reported by Canadian surgeon Jacques Turcot (1914-1977 ) et al. in 1959 and hence carries the first author's name. |urp| srb| sdb| zfm| hge| kow| ylt| uvv| tsr| wse| pnv| pmq| bmx| bjh| iuv| hxv| mab| nhq| sgi| rmg| bwb| tfz| pnv| ahj| dxl| eqy| akb| nss| zwb| nvn| ljh| osh| nzx| lzf| kra| oyj| tqu| pmz| yro| otd| tfj| jvs| zkv| wvz| uuz| pcd| syb| xsp| aoi| wnc|